Elevance Health Inc. provided earnings guidance for the fiscal year 2023. The Company expects GAAP net income to be greater than $29.80 per share in 2023. Operating revenue to be $164 billion.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
520.9 USD | -5.82% | -2.56% | +10.47% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+10.47% | 121B | |
+8.89% | 528B | |
+15.13% | 97.94B | |
-12.15% | 48.46B | |
-8.64% | 36.18B | |
-17.49% | 17.47B | |
-20.44% | 2.82B | |
+16.14% | 1.91B | |
+80.65% | 854M |
- Stock Market
- Equities
- ELV Stock
- News Elevance Health, Inc.
- Elevance Health Inc. Provides Earnings Guidance for the Fiscal Year 2023